Emergent BioSolutions Inc. has grown revenue −13% a year over three years and −14% a year over five. Revenue growth, 3-year annual rate: −13% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: −14%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

EBSEmergent BioSolutions Inc.

Healthcare

$6.81-31% 1Y

$6.81

$4.4552 weeks$13.90

Is it growing?

Is EBS growing?

Emergent BioSolutions Inc. has grown revenue −13% a year over three years and −14% a year over five.

−13%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −14%
Revenue growth, 5-year rate · −13% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›